ARCHIVES

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | March 24, 2006

Download PDF Visit The Full Archive

Related Articles

Seer Gets Concept Approval For Three More Years, With Several Changes

June 19, 1981

NCI Tells CCOPs To Slow Patient Accrual To Clinical Trials, Prepare For Budget Cuts.

May 12, 2006

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992

NCI Cooperative Group Trials Approved Last Month By CTEP

March 26, 2010

Guest Editorial: FDA Must Address Economic Incentives to Resolve Drug Shortages Permanently

February 24, 2012

In Brief: NCAB Will Consider Holding “Circuit Rider” Meetings; Kaplan Asked to Speak On Hybridomas

May 1, 1981